These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22976524)

  • 1. Vitamin D metabolism and activity as well as genetic variants of the vitamin D receptor (VDR) in chronic kidney disease patients.
    Santoro D; Caccamo D; Gagliostro G; Ientile R; Benvenga S; Bellinghieri G; Savica V
    J Nephrol; 2013; 26(4):636-44. PubMed ID: 22976524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease.
    Bover J; Egido J; Fernández-Giráldez E; Praga M; Solozábal-Campos C; Torregrosa JV; Martínez-Castelao A
    Nefrologia; 2015; 35(1):28-41. PubMed ID: 25611831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current Topics on Vitamin D. Vitamin D and chronic kidney disease].
    Nakagawa Y; Koizumi M; Fukagawa M
    Clin Calcium; 2015 Mar; 25(3):413-23. PubMed ID: 25716815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of vitamin D receptor polymorphisms on biochemical markers of mineral bone disorders in South African patients with chronic kidney disease.
    Waziri B; Dix-Peek T; Dickens C; Duarte R; Naicker S
    BMC Nephrol; 2018 Feb; 19(1):30. PubMed ID: 29415666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitamin D metabolism and current options for therapeutic activation of vitamin D receptor in patients with chronic kidney disease or renal failure].
    Dusilová Sulková S
    Vnitr Lek; 2012 Nov; 58(11):839-49. PubMed ID: 23256830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease.
    Obi Y; Hamano T; Isaka Y
    Dis Markers; 2015; 2015():868961. PubMed ID: 25883412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitamin D: synthesis, metabolism, regulation, and an assessment of its deficiency in patients with chronic renal disease].
    Spustová V; Dzúrik R
    Vnitr Lek; 2004 Jul; 50(7):537-43. PubMed ID: 15323262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
    Sprague SM; Coyne D
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):512-8. PubMed ID: 20133492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D in chronic kidney disease.
    Dusso A; González EA; Martin KJ
    Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):647-55. PubMed ID: 21872805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation of gene expression and vitamin].
    Takeda E; Yamamoto H; Miyamoto K
    Nihon Rinsho; 1999 Oct; 57(10):2295-300. PubMed ID: 10540876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D treatment in chronic kidney disease.
    Andress DL
    Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D Metabolism and Potential Effects of Vitamin D Receptor Modulation in Chronic Kidney Disease.
    Bellasi A; Galassi A; Mangano M; Di Lullo L; Cozzolino M
    Curr Drug Metab; 2017; 18(7):680-688. PubMed ID: 28460623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines for vitamin D prescription in dialysis patients].
    Jean G; Lafage-Proust MH; Massy ZA; Drüeke TB
    Nephrol Ther; 2009 Nov; 5(6):520-32. PubMed ID: 19748843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor activation and cardiovascular disease.
    Gonzalez-Parra E; Rojas-Rivera J; Tuñón J; Praga M; Ortiz A; Egido J
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv17-21. PubMed ID: 23258805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease.
    Santoro D; Lucisano S; Gagliostro G; Alibrandi A; Benvenga S; Ientile R; Bellinghieri G; Buemi M; Caccamo D
    J Ren Nutr; 2015 Mar; 25(2):187-93. PubMed ID: 25499229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients.
    Baur K; Mertens JC; Schmitt J; Iwata R; Stieger B; Eloranta JJ; Frei P; Stickel F; Dill MT; Seifert B; Ferrari HA; von Eckardstein A; Bochud PY; Müllhaupt B; Geier A;
    Liver Int; 2012 Apr; 32(4):635-43. PubMed ID: 22151003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states.
    Uitterlinden AG; Fang Y; van Meurs JB; van Leeuwen H; Pols HA
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):187-93. PubMed ID: 15225770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
    McCann LM; Beto J
    J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.